The UK clinical artificial intelligence (AI) firm Sensyne has announced agreements with a Fortune 200 company, and a data infrastructure specialist, to launch and grow its digital health pr
Artificial intelligence company Sensyne Health has launched a new app that helps women manage gestational diabetes, and five NHS hospitals have already signed up.
Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care" drug for the common skin disorder.
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.